The initial muscle loss seen with GLP-1 RA treatment as well as the ongoing replacement of muscle with fat with treatment cycles involving treatment interruptions can result in unfavorable changes in body composition in patients with obesity that can have profoundly negative repercussions, and can exacerbate obesity-related metabolic and health concerns 14,15,16
Dehydration occurs when the body does not have enough fluid to function properly and commonly causes fatigue, dizziness, and weakness
Without knowing which compound caused the problem, you end up either reducing both unnecessarily or guessing wrong and suffering through avoidable symptoms
What we need to be cautious about Crucially, most of the new uses for these medications havent yet been tested in proper clinical trials
Lek zosta opracowany przez amerykask firm farmaceutyczn Eli Lilly and Company i jest dostpny w formie roztworu do wstrzykiwa pod nazw handlow Mounjaro
Tardy BL, Mattos BD, Otoni CG et al (2021) Deconstruction and reassembly of renewable polymers and biocolloids into next generation structured materials
